{
    "nct_id": "NCT02967458",
    "official_title": "Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study",
    "inclusion_criteria": "1. Subject must be scheduled for a clinically indicated needle biopsy of the prostate based upon an elevated PSA, abnormal digital rectal examination, or based upon active surveillance of prostate cancer.\n2. Subject must be able and willing to give written informed consent for a contrast enhanced ultrasound study of the prostate.\n3. Subject must be a male at least 18 years of age when informed consent is obtained.\n4. Subject must have a life expectancy that exceeds the duration of the clinical trial.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Participant in a clinical trial involving an investigational drug within the past 30 days.\n2. Prior allergic reaction to the ultrasound contrast agent Definityâ„¢\n3. Previous treatment for PCa.\n4. Clinically unstable, severely ill, or moribund.",
    "miscellaneous_criteria": ""
}